Based on plasma analyses, the combination of three methylated genes, CDH13, APC, and RASSF1A in patients with NSCLC was found to provide high sensitivity and specificity (71.82 and 80%, respectively) in plasma for NSCLC diagnosis. The gene discussed is RASSF1; the disease is non-small cell lung carcinoma.